Skip to Main Content

Paper Details

DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
Journal of Neuro-Oncology
1
2022
ACM, CNS sarcoma, CNS tumors, DICER1, DICER1 functional domains, DICER1 mutations, DUF283, DexD/H-box helicase, DexD/H-box helicase domain, IDH1, IDH1 R132 mutation, MGMT, R132, RNaseIIIa, RNaseIIIb, RNaseIIIb domains, Sarcoma, chromosome 14q, glioma, grade 1/2 glioma, grade 3/4 glioma, grade 3/4 gliomas, malignancies, patients, primary, primary CNS tumors, primary central nervous system tumors, tumors
Author NameAffiliation
Kevin X LiuHarvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School
Keith L LigonHarvard Medical School, Brigham and Women's Hospital
Sanda AlexandrescuHarvard Medical School Boston, Boston Children's Hospital
Daphne A Haas-KoganHarvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute
  • 1 - 5

Datasets

Release 1.2